Psychiatry and Neurology, Neurology · New York, NY
NPI
1073716775
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
710 W 168th St
New York, NY, 10032
Phone (212) 305-6788
Groups this clinician bills Medicare through
Medicare paid, 2024
$57K
789 services
Medicare patients, 2024
309
Average age 72
Drug cost, 2024
$6.6M
1,668 prescriptions
Company payments, 2025
$12K
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kelly G Gwathmey was code 99215 (office e&m - established), 160 times for 88 patients. In total Kelly G Gwathmey billed 789 services in 23 codes, and Medicare paid $57K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 160 | 88 | $106.96 | $17K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 118 | 80 | $12.51 | $1,477 |
| 99214 Office E&M - Established | Office | 100 | 83 | $68.15 | $6,815 |
| 99205 Office E&M - New | Office | 59 | 59 | $126.58 | $7,468 |
| 95885 Electrical Nerve Conductivity | Office | 49 | 36 | $31.68 | $1,552 |
| 95886 Electrical Nerve Conductivity | Office | 44 | 37 | $52.11 | $2,293 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 33 | 13 | $23.96 | $791 |
| 99214 Office E&M - Established | Facility | 31 | 28 | $68.24 | $2,116 |
| 99213 Office E&M - Established | Office | 25 | 23 | $48.63 | $1,216 |
| 95911 Electrical Nerve Conductivity | Office | 17 | 17 | $140.20 | $2,383 |
| 99222 Hospital E&M - Initial | Facility | 14 | 13 | $99.13 | $1,388 |
| 95913 Electrical Nerve Conductivity | Office | 13 | 13 | $156.15 | $2,030 |
By year: 2022 $48K for 873 services; 2023 $50K for 620 services; 2024 $57K for 789 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kelly G Gwathmey prescribed most often to Medicare patients was Radicava Ors (Edaravone), with 227 prescriptions and refills. In total Kelly G Gwathmey wrote 1,668 Medicare prescriptions that cost $6.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Radicava Ors Edaravone | 227 | 227 | 34 | $3.2M |
| Riluzole Generic | 155 | 257 | 38 | $25K |
| Gabapentin Generic | 117 | 203 | 32 | $1,994 |
| Mycophenolate Mofetil Generic | 110 | 264 | 27 | $13K |
| Pyridostigmine Bromide Generic | 101 | 204 | 30 | $9,005 |
| Baclofen Generic | 85 | 194 | 28 | $2,891 |
| Nuedexta Dextromethorphan Hbr/Quinidine | 74 | 80 | Under 11 | $123K |
| Duloxetine Hcl Generic | 67 | 102 | 11 | $1,061 |
| Pregabalin Generic | 55 | 79 | 11 | $1,116 |
| Prednisone Generic | 54 | 90 | 16 | $368 |
| Relyvrio Sod Phenylbutyrat/Taurursodiol | 51 | 51 | 23 | $620K |
| Glycopyrrolate Generic | 40 | 84 | 12 | $1,775 |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 37 | 37 | Under 11 | $316K |
| Diazepam Generic | 32 | 33 | Under 11 | $137 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 27 | 35 | Under 11 | $137 |
Brand drugs: - claims; generic drugs: 1,186 claims; opioid claims: 15.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kelly G Gwathmey $12K ($12K in general payments such as food, travel and fees) from 7 companies. The largest payer was Argenx US, Inc. with $6,750.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.